| It certainly looks promising. The initial trials in Auckland and the recent trials in Russia have been encouraging. I think the biggest hurdle now is bureaucratic red tape. Bob Elliot is waiting for final approval to start the next phase of trials with six patients here in Auckland. This is a form of xenotransplantation and the retro virus risk is a big issue. There has been a lot of debate on it and it seemed like everything had been sorted out, but the minister of health is dragging his heals on giving his approval. It is an election year here and it looks like there will be a change of government, so I don't expect anything to happen soon. LCT might try and shift the trials to the US, but I suspect there will be complications there too.
__________________
In my humble opinion
Type1 since 1977
MDI using Lantus, Protophane, Novorapid and Actrapid
|